By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK)

HKSE Currency in HKD
$42.00
-$2.48
-5.58%
Last Update: 1 Sept 2025, 05:23
$19.19B
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$41.40 - $74.00
52 Week Range

2591.HK Stock Price Chart

Explore Guangzhou Innogen Pharmaceutl Grp Co Ltd interactive price chart. Choose custom timeframes to analyze 2591.HK price movements and trends.

2591.HK Company Profile

Discover essential business fundamentals and corporate details for Guangzhou Innogen Pharmaceutl Grp Co Ltd (2591.HK) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

15 Aug 2025

Employees

CEO

Description

Guangzhou Innogen Pharmaceutl Grp Co Ltd is a China-based investment holding company focused on the research, development, and commercialization of pharmaceutical products, particularly innovative, humanized, long-acting GLP-1 receptor agonists for diabetes and other metabolic diseases

2591.HK Financial Timeline

Browse a chronological timeline of Guangzhou Innogen Pharmaceutl Grp Co Ltd corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

2591.HK Stock Performance

Access detailed 2591.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run